 |
|
|
| |
Identification and Characterization of PPI-461, a Potent and Selective HCV NS5A Inhibitor with Activity Against all HCV Genotypes
|
| |
| |
Reported by Jules Levin
EASL Apr 14-18 2010 Vienna Austria
Richard Colonno, Ningwu Huang, Margaret Bencsik, Eric Peng, Anja Huq, Qi Huang, Min Zhong and Leping Li Presidio Pharmaceuticals, San Francisco, CA, USA
1Nettles et al. Poster 893, AASLD 2008
|
| |
|
|
|
|
|
